Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.
Researchers developed a tablet-based software application designed to slow cognitive and communicative decline in individuals with Alzheimer's disease for home use. A randomized controlled trial with 32 participants (mild, moderate, and severe stages) compared outcomes between those using the application plus pharmacological treatment versus pharmacological treatment alone.
This health economics study examines costs associated with using neuroimaging (PET and MRI) to identify Alzheimer's disease patients most likely to benefit from lecanemab treatment over three years. The authors highlight a critical concern: approximately 78% of patients with mild cognitive impairment do not progress to dementia, making prophylactic treatment in all MCI patients costly and ethically problematic; they identify combined fluorodeoxyglucose and MRI imaging as the most cost-efficient approach at $177,000 per positive outcome with adjusted lecanemab pricing.
This neuroimaging study compared brain structural connectivity in 25 individuals with gambling disorder versus 28 healthy controls using diffusion tensor imaging and probabilistic tractography. The gambling disorder group showed increased striatal connectivity but reduced frontal lobe connectivity and fewer neural hubs, suggesting impaired network integration related to risk-taking control.
This randomized controlled trial compares two AI-delivered psychotherapy approaches—psychodynamic and cognitive behavioral therapy—for treating social anxiety disorder. The study evaluates the efficacy of automated therapy systems in delivering evidence-based interventions.
This study examines apathy as a frequently underrecognized feature of major depressive disorder in 154 outpatients, finding apathy present in 48% of the sample and associated with higher depression severity, lower cognitive function, and reduced quality of life. The research identifies specific depressive symptoms—inability to feel and loss of interest—as the strongest predictors of apathy, suggesting it represents a distinct clinical dimension warranting greater clinical attention.